The aims of Jun's research are
- to understand the molecular basis of obesity, type 2 diabetes, and heart and kidney complications associated with obesity and diabetes;
- to identify novel targets to treat those diseases;
- to find pharmacological treatment based on new targets;
- to search for compounds from natural products for the treatment of cancer, obesity, diabetes and cardiovascular complications (including renal system) associated with obesity and diabetes;
- to synthesise novel compounds based on rational design for the treatment of cancer and cardiac complication of obesity and diabetes;
- to discover and develop neutraceutical products with health benefits.
I also have three research hobbies which are:
- Use modern biomedical technology to study marine animals (i.e. using MRI technology to study fish hearing structure);
- Use bioinformatics tools to study micro-organism in various environmental samples;
- Maori and Chinese interactions in New Zealand.
Jun's expertise lies in the following areas:
- Pre-clinical and clinical pharmacology, especially drug metabolism and pre-clinical drug testing using animal models and cultured cell lines;
- Analytical chemistry, characterisation and quantification of molecules of interest;
- Medical imaging using MRI;
- Polyamine metabolism and energy metabolism;
- Cardiovascular and renal function determination and biomarker identification
Jun's technical expertise including imaging using High-Field MRI and clinical MRI, chemical analysis using HPLC, LC-MS and GC-MS, animal experimentation, in vitro tissue experimentation, molecular biology technology and cell line experimentation.